Schmitz, Katja
Article History
Received: 17 November 2023
Accepted: 12 December 2023
First Online: 5 January 2024
Conflict of interest
: K. Schmitz received honoraria as advisor or speaker from: Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi-Sankyo, Diaceutics, Incyte, Janssen-Cilag, Eli Lilly, Merck, Merck Sharp and Dohme, Novartis Pharma, Pfizer, PharmaMar, Roche Pharma, Servier, Stemline, Takeda, Targos GmbH, and ZytoVision. K. S. received travel support from AstraZeneca, Merck, Novartis and PharmaMar.